Oligonucleotides containing pyrazolo 3,4-d]pyrimidines for hybridization and mismatch discrimination
Abstract
(57) The oligonucleotide by which the summary singular number or two or more pudding 残 machines were replaced by ピラゾロ 3, 4*d pyrimidine shows the improved hybridization characteristic. The oligonucleotide which has the 3 and 4*ピラゾロ d pyrimidine base analog has a dissolution temperature higher than the non-replacing oligonucleotide of the same arrangement. Therefore, a higher signal is acquired in the assay containing the hybridization of an oligonucleotide probe to target polynucleotide. Furthermore, when the 3 and 4*ピラゾロ d pyrimidine content oligonucleotide is used as a hybridization probe, Inharmonious distinctiveness improves and let them be things useful as the probe and primer for a hybridization, amplification and a sequence determination procedure, and the thing for which inharmonious discernment of singleness or plurality, and a nucleotide is needed especially.
Term
No projected expiry on record.
- Priority
- Filed
- Granted
- Today
101 members in 12 offices
Priority claims1
| Document | Office | Kind | Date |
|---|---|---|---|
| 5483098 | United States of America | A |
Members101
| Document | Office | Kind | |
|---|---|---|---|
| CA2223678A1 | Canada | A1 | |
| WO9632496A2 | World Intellectual Property Organization (WIPO) | A2 | |
| AU5384296A | Australia | A | |
| WO9632496A3 | World Intellectual Property Organization (WIPO) | A3 | |
| EP0819133A2 | European Patent Office (EPO) | A2 | |
| CN1186496A | China | A | |
| US5801155A | United States of America | A | |
| JPH11504626A | Japan | A | |
| CA2327547A1 | Canada | A1 | |
| CA2329135A1 | Canada | A1 | |
| WO9951621A2 | World Intellectual Property Organization (WIPO) | A2 | |
| WO9951775A1 | World Intellectual Property Organization (WIPO) | A1 | |
| AU3472199A | Australia | A | |
| AU3472499A | Australia | A | |
| AU716108B2 | Australia | B2 | |
| US6084102A | United States of America | A | |
| US6127121A | United States of America | A | |
| EP1068358A1 | European Patent Office (EPO) | A1 | |
| CA2401781A1 | Canada | A1 | |
| WO0164958A2 | World Intellectual Property Organization (WIPO) | A2 | |
| AU4340301A | Australia | A | |
| EP1144429A2 | European Patent Office (EPO) | A2 | |
| US6312894B1 | United States of America | B1 | |
| WO9951621A3 | World Intellectual Property Organization (WIPO) | A3 | |
| WO0164958A3 | World Intellectual Property Organization (WIPO) | A3 | |
| JP2002510507A | Japan | A | |
| US2002052482A1 | United States of America | A1 | |
| US6426408B1 | United States of America | B1 | |
| JP2002527040A | Japan | A | |
| EP1144429A3 | European Patent Office (EPO) | A3 | |
| US2002146690A1 | United States of America | A1 | |
| US6485906B2 | United States of America | B2 | |
| US6486308B2 | United States of America | B2 | |
| EP1261616A2 | European Patent Office (EPO) | A2 | |
| US6492346B1 | United States of America | B1 | |
| AU759944B2 | Australia | B2 | |
| US2003143602A1 | United States of America | A1 | |
| AU763948B2 | Australia | B2 | |
| JP2003525292A | Japan | A | |
| US2003224359A1 | United States of America | A1 | |
| CA2490466A1 | Canada | A1 | |
| WO03107144A2 | World Intellectual Property Organization (WIPO) | A2 | |
| US2003235822A1 | United States of America | A1 | |
| AU2003247571A1 | Australia | A1 | |
| US6683173B2 | United States of America | B2 | |
| US2004058322A1 | United States of America | A1 | |
| WO03107144A3 | World Intellectual Property Organization (WIPO) | A3 | |
| CN1187363C | China | C | |
| US2005064463A1 | United States of America | A1 | |
| US2005075491A1 | United States of America | A1 | |
| US6884584B2 | United States of America | B2 | |
| EP1537488A2 | European Patent Office (EPO) | A2 | |
| CN1644585A | China | A | |
| US6949367B1 | United States of America | B1 | |
| JP2005532618A | Japan | A | |
| US2006003349A1 | United States of America | A1 | |
| US2006009628A1 | United States of America | A1 | |
| EP1068358B1 | European Patent Office (EPO) | B1 | |
| AT320508TThis record | Austria | T | |
| ATE320508T1 | Austria | T1 | |
| DE69930379D1 | Germany | D1 | |
| US7045610B2 | United States of America | B2 | |
| DE69930379T2 | Germany | T2 | |
| EP0819133B1 | European Patent Office (EPO) | B1 | |
| AT382627T | Austria | T | |
| ATE382627T1 | Austria | T1 | |
| DE69637389D1 | Germany | D1 | |
| PT819133E | Portugal | E | |
| US7368549B2 | United States of America | B2 | |
| DK0819133T3 | Denmark | T3 | |
| ES2300106T3 | Spain | T3 | |
| EP1537488A4 | European Patent Office (EPO) | A4 | |
| EP1944310A2 | European Patent Office (EPO) | A2 | |
| EP1944310A3 | European Patent Office (EPO) | A3 | |
| EP1975256A1 | European Patent Office (EPO) | A1 | |
| EP1995330A1 | European Patent Office (EPO) | A1 | |
| DE69637389T2 | Germany | T2 | |
| US2009048427A1 | United States of America | A1 | |
| US7556923B1 | United States of America | B1 | |
| EP1144429B1 | European Patent Office (EPO) | B1 | |
| DE69941130D1 | Germany | D1 | |
| CA2223678C | Canada | C | |
| CA2327547C | Canada | C | |
| US7715989B2 | United States of America | B2 | |
| US7751982B2 | United States of America | B2 | |
| EP1261616B1 | European Patent Office (EPO) | B1 | |
| US2010228017A1 | United States of America | A1 | |
| US7794945B2 | United States of America | B2 | |
| AT478085T | Austria | T | |
| ATE478085T1 | Austria | T1 | |
| DE60142828D1 | Germany | D1 | |
| JP4558932B2 | Japan | B2 | |
| CN101914099A | China | A | |
| ES2350193T3 | Spain | T3 | |
| JP4638032B2 | Japan | B2 | |
| US2011275070A1 | United States of America | A1 | |
| JP4948690B2 | Japan | B2 | |
| EP1975256B1 | European Patent Office (EPO) | B1 | |
| ES2391213T3 | Spain | T3 | |
| US8465921B2 | United States of America | B2 |
1 legal event, as the office reported them to INPADOC
Events
| Event | Code | |
|---|---|---|
| Ceased as to paragraph 5 lit. 3 law introducing patent treatiesCeasedRER | RER |
Numbers
- Application
- 99916394
Titles2
- German
- OLIGONUKLEOTIDE MIT PYRAZOL(3,4-D) PYRIMIDIN ZUR HYBRIDISIERUNG UND UNTERSCHEIDUNG VON FEHLPAARUNGEN
- English
- OLIGONUCLEOTIDES WITH PYRAZOL (3,4-D) PYRIMIDINE FOR HYBRIDIZING AND DISTINGUISHING MALFUNCTION
Classification
- CPC, 3
- C12Q1/6818
- C12Q1/6827
- C12Q1/6832
- IPC, 5
- C12N15 09
- C12Q1 68
- C12Q1 6818
- C12Q1 6827
- C12Q1 6832